MDB PHARMA
ActiveSummary
MDB PHARMA has been active since 2021 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €190,172 and a net result of €59,366. Equity is growing by about 44% per year across the filed financial years. Its solvency ranks better than 93% of 22,595 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
History
Acts, filings and financial milestones
16-03
Gazette deed
Registered officeRegistered-office move3 facts ▸
- Other provision, “publication number”, 26037853 (deed in Dutch)
- Board meeting, 28-03-2025
- Registered-office move, lepenstraat 70, 9000 Gent
About the unread acts
Of the 3 Belgian Official Gazette deeds we know for this company, 1 has been read. The other 2 have not been read yet: what they contain is neither established nor disproved here.